Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.77 USD | -2.58% | 0.00% | -45.02% |
Business Summary
Number of employees: 49
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Artificial Intelligence-Immunology Powered Vaccines
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Denmark
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andreas Mattsson
FOU | Founder | - | 08-08-10 |
Niels Møller
FOU | Founder | 46 | 08-08-10 |
Chief Executive Officer | 52 | 23-08-28 | |
Director of Finance/CFO | 54 | 22-03-13 | |
Birgitte Rono
CTO | Chief Tech/Sci/R&D Officer | 47 | 17-08-31 |
Sabine Mølleskov
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 54 | 17-12-31 | |
Lars Holtug
BRD | Director/Board Member | 66 | 21-05-24 |
Marianne Søgaard
CHM | Chairman | 56 | 17-12-31 |
Niels Møller
FOU | Founder | 46 | 08-08-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,897,780 | 31,606,749 ( 83.40 %) | 0 | 83.40 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.56% | 20.94M | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.47% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
-1.62% | 11.98B |
- Stock Market
- Equities
- EVAX Stock
- Company Evaxion Biotech A/S